Quercis Pharma, established in 2019, is a Swiss-based company rooted deeply in the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. With the inspiring slogan, "For a Healthier World," Quercis Pharma is pioneering innovative and safe antithrombotic solutions. Their primary mission is to tackle complex diseases inadequately managed by current medical solutions, emphasizing affordable access to their essential therapies.
In a significant boost to their journey, Quercis Pharma secured a notable $150.00M in a Private Equity Round on 09 December 2021. This investment was led by Global Emerging Markets, highlighting strong investor confidence in their potential to innovate within the healthcare space.
For investors focused on groundbreaking advancements in healthcare, Quercis Pharma represents a compelling opportunity with its robust platform and strategic growth trajectory. As it continues to evolve, stakeholders can anticipate its pivotal role in transforming therapeutic solutions globally.